Stuart Chaussee & Associates’s GoodRx Holdings GDRX Stock Holding History

Stuart Chaussee & Associates’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-880	Closed	-$17K	–	162
2022 Q1	$17K	Hold	880	–	–	0.01%	91
2021 Q4	$29K	Hold	880	–	–	0.01%	64
2021 Q3	$36K	Hold	880	–	–	0.06%	45
2021 Q2	$32K	Hold	880	–	–	0.01%	55
2021 Q1	$34K	Hold	880	–	–	0.01%	59
2020 Q4	$35K	Hold	880	–	–	0.01%	52
2020 Q3	$49K	Buy	+880	New	+$46.6K	0.02%	41

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Stuart Chaussee & Associates's GDRX Position: Q2 2022 in Review

Stuart Chaussee & Associates sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 880 shares — an estimated $17K sold.

Stuart Chaussee & Associates first reported a position in GDRX in Q3 2020 and held it in 7 quarters. The position peaked at $49K in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Stuart Chaussee & Associates reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Stuart Chaussee & Associates sold 880 GoodRx Holdings shares in Q2 2022, an estimated $17K.
Stuart Chaussee & Associates first reported a position in GoodRx Holdings in Q3 2020 and held it in 7 quarters.
Stuart Chaussee & Associates's GoodRx Holdings position peaked at $49K in Q3 2020.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Stuart Chaussee & Associates's 13F filing for Q2 2022, filed 15 Jul 2022.